Beacon Medical

What Beacon Medical does

Beacon Medical is an Australian pharmaceutical distribution company that supplies medical cannabis and alternative therapy products to patients through a regulated prescriber pathway. Founded in 2015, the company operates as a wholly owned subsidiary of Medipharm Labs, a TSX-listed Canadian pharmaceutical manufacturer with roots tracing to VIVO's 2013 medicinal product distribution business. The company addresses three primary customer segments: patients with chronic medical conditions in Australia seeking alternatives after conventional treatment failure, registered Australian doctors who prescribe these therapies under TGA oversight, and pharmacists who dispense them. Patients access products only via a registered prescriber who has obtained health authority approval; Beacon Medical does not sell directly to consumers.

The product portfolio comprises pharmaceutical-grade cannabis-derived therapeutics in multiple formats—flowers, edibles, oils, and topical treatments—with varying cannabinoid, terpene, and flavonoid compositions. Manufacturing relies on the parent company's indoor GMP production facilities with full environmental control for strain consistency, GMP extraction facilities accessed through Medipharm Labs, and quality assurance processes inspected by Health Canada and third parties. The company complements these products with educational content libraries covering terpene profiles, dosing, applications, and current stock for prescribers and dispensers.

Commercially, Beacon Medical runs a healthcare-professional-led go-to-market model. Marketing and onboarding occur through the company website (beaconmedical.com.au), supported by dedicated sign-up portals for patients, doctors (AHPRA number required), and pharmacists, plus organic social channels. Distribution is indirect, mediated entirely through prescribing doctors and dispensing pharmacists under TGA regulation. Pricing is not publicly disclosed; the company does not publish revenue figures, and the parent Medipharm Labs is the only listed entity, making Beacon Medical's standalone financial profile inferred rather than reported.

Name

Beacon Medical

Legal name

Beacon Medical

Website

https://beaconmedical.com.au

Company type

Private

Founded year

2015

Operating status

Operating

Short description

Beacon Medical is the Australian subsidiary of TSX-listed Medipharm Labs, distributing pharmaceutical-grade medical cannabis products—including flowers, oils, edibles, and topicals—through a TGA-regulated prescription pathway to chronic-condition patients via their prescribing doctors and dispensing pharmacists.

Ownership category

akta.pro rank

Product category

Medical Cannabis Manufacturing

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)

Keywords

• Pharmaceutical medical cannabis
• Medicinal cannabis manufacturing
• Alternative therapy products
• GMP-certified cannabis production
• Cannabis healthcare education

Headquarters

HQ city

Napanee

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Marketing or Sales, Technology or R&D

Revenue model

1. Alternative Therapy Products: Sale of pharmaceutical-grade alternative therapy products including flowers, edibles, oils, and topical treatments. Products are distributed through prescribing doctors and dispensing pharmacists in Australia.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Beacon Medical develops and supplies pharmaceutical-grade medical cannabis products — flowers, edibles, oils, and topical treatments — for patients, doctors, and pharmacists in Australia. The company also provides educational materials and content libraries to support healthcare professionals and patients around alternative therapy use.

Product overview

Beacon Medical offers a portfolio of pharmaceutical-grade alternative therapy products derived from natural plant sources, distributed across Australia. The product line includes flowers, edibles, oils, and topical treatments, each containing varying levels of active molecules (cannabinoids) with additional terpenes and flavonoids. The company serves three primary segments: patients seeking alternative treatments (accessed through prescribing doctors), healthcare professionals (doctors who can prescribe), and pharmacists who dispense the medications. Supporting the core product offerings are educational resources and content libraries specifically designed for health professionals to better understand the alternative medicine ecosystem, including information on terpenes, dosing, and applications.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical-grade medical cannabis product range Pharmaceutical-grade medical cannabis products manufactured under TGA GMP certification and supplied through prescribing doctors and dispensing pharmacists to patients in Australia. The range includes flowers, edibles, oils, and topical treatments as alternative therapy options.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Medipharm LabscoreOEM/ Whitelabel/ Licensing PartnerMedipharm Labs is a Canadian TSX-listed company and the parent company of Beacon Medical Australia. Medipharm Labs has been growing, extracting, and selling pharmaceutical-grade products since 2014, holding four manufacturing licenses in Canada and a GMP Manufacturing license from TGA. Beacon Medical Australia serves as a conduit for bringing Medipharm Labs' knowledge, products, and manufacturing capabilities to Australian patients.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Aurora Cannabis: Global GMP-licensed medical cannabis producer with a multi-country footprint; competes in the same medical-cannabis category as Beacon, though at significantly greater scale and across broader product lines.
• Cronos Group: Global cannabis operator with medical-cannabis products and GMP capabilities; comparable in product category and regulatory positioning though operating at materially larger scale.
• Canopy Growth: Major global cannabis company with medical-cannabis operations across multiple jurisdictions including Australia; addresses overlapping patient populations and prescriber channels.
• Tilray Brands: Large global cannabis company with Australian operations supplying medical cannabis products; broader portfolio and bigger scale than Beacon, but overlapping on the medical-cannabis category and pharmacy-channel distribution.

Direct peers

• Cann Group: ASX-listed Australian medical cannabis company with its own cultivation and manufacturing facilities, supplying GMP-certified medicinal cannabis products to Australian patients through prescribers and pharmacies.
• Little Green Pharma: ASX-listed Australian medical cannabis cultivator, manufacturer, and distributor selling GMP-produced flower and oil products via the same prescribing-doctor and dispensing-pharmacy pathway as Beacon Medical.
• Althea Group Holdings: ASX-listed Australian medical cannabis supplier that distributes a range of products via healthcare professionals and pharmacies, overlapping directly with Beacon Medical's prescriber-channel business model.

Emerging players

• Bod Australia: ASX-listed Australian company developing and distributing medicinal cannabis and hemp-based health products, with overlapping prescriber and pharmacy channels though smaller scale than Beacon's parent ecosystem.
• MGC Pharmaceuticals: ASX-listed medicinal cannabis company producing and distributing phytocannabinoid products through pharmacy and prescriber channels in Australia and Europe, comparable niche focus to Beacon Medical.
• Medlab Clinical: ASX-listed Australian pharmaceutical company with medicinal cannabis products in its portfolio, distributed through healthcare professionals; partial overlap with Beacon's medical-cannabis offering and prescriber-led GTM.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/BeaconMedicalCA
• Facebookfacebook.com/BeaconMedicalCanada
• Instagraminstagram.com/beaconmedicalcannabis/?hl=en

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Beacon Medical